Status:

NOT_YET_RECRUITING

The RESPLASH Study

Lead Sponsor:

Tulane University

Conditions:

Resistant Hypertension

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

To assess the safety and effectiveness of renal artery denervation with subsequent splanchnic nerves denervation via catheter-based radiofrequency ablation in improving blood pressure and glycemic con...

Detailed Description

The investigators propose a multicenter, prospective, single blind, randomized controlled pilot study. Patients with treatment-resistant hypertension and diabetes mellitus type 2 will be enrolled to u...

Eligibility Criteria

Inclusion

  • Patients aged 18-75.
  • History of Type 2 Diabetes Mellitus at least 5 years prior to enrollment.
  • HbA1c level ≥6.5%
  • Use of at least 1 oral antidiabetic agent and no changes in the last 30 days.
  • History of essential hypertension with systolic Blood pressure of 160 mmHg or more (≥150 mmHg in patient with Type 2 Diabetes Mellitus), despite compliance with three of more antihypertensive drugs.
  • Stable drug regimen of at least 3 antihypertensive medications with no changes for 2 weeks before enrollment.

Exclusion

  • Estimated glomerular filtration rate of less than 30 mL/min per 1.73m2.
  • Type 1 diabetes mellitus.
  • History of aortic pathologies such as aneurysm or dissection confirmed by immediate preprocedural angiography that would preclude the Endovascular Denervation (EDN) procedure.
  • Orthostatic hypotension.
  • Acute or severe systemic infection.
  • History of myocardial infarction, unstable angina, or cerebrovascular accident in the previous 3 months.
  • History of previous renal artery CDN.
  • Pregnancy or planned pregnancy during the study period.
  • Unable to provide informed consent.

Key Trial Info

Start Date :

January 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2027

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06880562

Start Date

January 1 2026

End Date

January 1 2027

Last Update

November 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

East Jefferson General Hospital

New Orleans, Louisiana, United States, 70006